International Journal of Obesity · Nov 16, 2026

A systematic review and meta-analysis exploring the effects of tDCS on metabolic syndrome parameters in adults

By Ageeli M, Lopes M, İnce B et al.

Background: Metabolic syndrome is a group of health conditions associated with obesity, increased risk of type 2 diabetes, cardiovascular disease and mortality. Interventions, including lifestyle changes, pharmacological treatments, and surgical interventions, have limited long-term efficacy, and do not adequately address some underpinning factors in overweight/obesity, such as cognitive/inhibitory control related to eating behaviours. There is emerging evidence for the successful use of neuromodulation techniques, such as transcranial direct current stimulation (tDCS), as potential adjunctive therapies for eating and weight disorders. This systematic review and meta-analysis have investigated the potential effects of tDCS on weight and metabolic parameters, in adults with or without excess body weight. Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, a systematic search of Embase, PsychInfo and PubMed electronic databases was performed to identify randomised clinical trials (RCTs) of tDCS which reported at least one metabolic syndrome parameter. Primary outcomes were weight, body mass index (BMI), waist circumference, blood pressure, blood glucose, insulin, and lipid profile. Results: A total of 28 studies (1129 participants) were included. tDCS protocols varied in stimulation sites, current intensity, and number and duration of sessions. Meta-analyses showed small but statistically significant weight loss (MD = −1.16 kg, 95% CI: −2.29 to −0.02; p = 0.04) and waist circumference reduction (MD = −0.67 cm, 95% CI: −1.14 to −0.19; p = 0.02) following active tDCS compared to sham. A non-significant reduction in food cravings traits was observed (SMD = −0.21, p = 0.06). Effects on glucose and blood pressure were variable. Conclusion: The modest positive effects of tDCS on weight and waist circumference, nonetheless, highlight its potential clinical relevance for treating obesity and metabolic syndrome. Well-powered RCTs using standardised assessment procedures are essential to clarify the therapeutic mechanisms of tDCS and to identify optimal dosing for this population.

doi.org/10.1038/s41366-026-02242-9Open accessPubMed 43039961Interventions

AgingResearch.News